GlassScriptPhysician profile
Agata K Brys
NPI 1447273487
$2,097.27
in general payments reported to CMS, 2019-2025
21 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.99 · 2020: $121 · 2021: $200 · 2022: $271 · 2023: $309 · 2024: $586 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,406.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $597.20 | 2020-2025 | |
| Aerin Medical INC. | $438.02 | 2022-2025 | |
| Glaxosmithkline, LLC. | $255.94 | 2021-2025 | Nucala, Trelegy Ellipta |
| Novartis Pharmaceuticals Corporation | $128.33 | 2019-2025 | |
| Optinose US, INC. | $123.66 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $98.69 | 2024-2025 | Cuvitru |
| Stryker Corporation | $66.33 | 2019-2020 | |
| Leo Pharma INC. | $59.71 | 2022-2023 | Adbry |
| Davol INC. | $42.48 | 2021 | |
| Csl Behring | $42.13 | 2024-2025 | Hizentra |
| Grifols USA, LLC | $40.54 | 2025 | Xembify |
| Allergan, INC. | $39.85 | 2021 | |
| Alk-Abello, INC | $38.52 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $31.83 | 2024 | Airsupra |
| Blueprint Medicines Corporation | $19.78 | 2024 | Ayvakit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $14.78 | 2024 | Ryaltris |
| Abbvie INC. | $14.66 | 2024 | |
| Sanofi-Aventis U.S. LLC | $14.48 | 2020 | |
| Medtronic USA, INC. | $12.90 | 2019 | |
| Ethicon US, LLC | $11.44 | 2020 | |
| Glenmark Therapeutics INC. | $6.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Agata Brys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.